Novel compounds protected under Enveric’s intellectual property portfolio provide potential licensing opportunities and non-dilutive revenue streams. CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric ...
Using artificial intelligence, researchers discovered a class of compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium that causes more than 10,000 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ...
Biotech partner would develop Enveric's three classes of compounds from its AI-powered drug discovery platform. Licensee to receive exclusive global licenses to develop and sublicense the three assets ...
A team of researchers led by Integrated Biosciences and the Massachusetts Institute of Technology have used a new form of artificial intelligence to discover a class of antibiotics capable of killing ...
Coordination chemistry of annulenes, porphyrin and related compounds. Credit: Nature (2025). DOI: https://doi.org/10.1038/s41586-025-08841-2 Coordination chemistry of ...
Antibiotic resistance is among the biggest global threats to human health. It was directly responsible for an estimated 1.27 million deaths in 2019 and contributed to nearly five million more. The ...
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders Novel compounds protected under Enveric’s intellectual property ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback